252 related articles for article (PubMed ID: 27557144)
1. Perspectives for treating Alzheimer's disease: a review on promising pharmacological substances.
Cazarim Mde S; Moriguti JC; Ogunjimi AT; Pereira LR
Sao Paulo Med J; 2016; 134(4):342-54. PubMed ID: 27557144
[TBL] [Abstract][Full Text] [Related]
2. Pharmacotherapy of Alzheimer's disease: an overview of systematic reviews.
Majidazar R; Rezazadeh-Gavgani E; Sadigh-Eteghad S; Naseri A
Eur J Clin Pharmacol; 2022 Oct; 78(10):1567-1587. PubMed ID: 35881170
[TBL] [Abstract][Full Text] [Related]
3. Treatment of Alzheimer's disease: current status and new perspectives.
Scarpini E; Scheltens P; Feldman H
Lancet Neurol; 2003 Sep; 2(9):539-47. PubMed ID: 12941576
[TBL] [Abstract][Full Text] [Related]
4. Cognitive enhancement therapy for Alzheimer's disease. The way forward.
Parnetti L; Senin U; Mecocci P
Drugs; 1997 May; 53(5):752-68. PubMed ID: 9129864
[TBL] [Abstract][Full Text] [Related]
5. Alkaloids Pharmacological Activities - Prospects for the Development of Phytopharmaceuticals for Neurodegenerative Diseases.
Chaves SK; Feitosa CM; da S Araújo L
Curr Pharm Biotechnol; 2016; 17(7):629-35. PubMed ID: 26718919
[TBL] [Abstract][Full Text] [Related]
6. Combination therapy for early Alzheimer's disease: what are we waiting for?
Doraiswamy PM; Steffens DC
J Am Geriatr Soc; 1998 Oct; 46(10):1322-4. PubMed ID: 9777922
[TBL] [Abstract][Full Text] [Related]
7. Vitamin E for Alzheimer's dementia and mild cognitive impairment.
Farina N; Llewellyn D; Isaac MGEKN; Tabet N
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD002854. PubMed ID: 28418065
[TBL] [Abstract][Full Text] [Related]
8. Vitamin E for Alzheimer's dementia and mild cognitive impairment.
Farina N; Llewellyn D; Isaac MG; Tabet N
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD002854. PubMed ID: 28128435
[TBL] [Abstract][Full Text] [Related]
9. Combination Therapy for the Treatment of Alzheimer's Disease: Recent Progress and Future Prospects.
Shirbhate E; Patel VK; Tiwari P; Kore R; Veerasamy R; Mishra A; Rajak H
Curr Top Med Chem; 2022; 22(22):1849-1867. PubMed ID: 36082857
[TBL] [Abstract][Full Text] [Related]
10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
11. Toward an early diagnosis and treatment of Alzheimer's disease.
Nordberg A
Int Psychogeriatr; 2003 Sep; 15(3):223-37. PubMed ID: 14756159
[TBL] [Abstract][Full Text] [Related]
12. Beyond immunotherapy: new approaches for disease modifying treatments for early Alzheimer's disease.
Ruthirakuhan M; Herrmann N; Suridjan I; Abraham EH; Farber I; Lanctôt KL
Expert Opin Pharmacother; 2016 Dec; 17(18):2417-2429. PubMed ID: 27825018
[TBL] [Abstract][Full Text] [Related]
13. Combination therapy in Alzheimer's disease: a review of current evidence.
Schmitt B; Bernhardt T; Moeller HJ; Heuser I; Frölich L
CNS Drugs; 2004; 18(13):827-44. PubMed ID: 15521788
[TBL] [Abstract][Full Text] [Related]
14. Pharmacotherapeutic approaches to the treatment of Alzheimer's disease.
Standridge JB
Clin Ther; 2004 May; 26(5):615-30. PubMed ID: 15220008
[TBL] [Abstract][Full Text] [Related]
15. The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model.
Bond M; Rogers G; Peters J; Anderson R; Hoyle M; Miners A; Moxham T; Davis S; Thokala P; Wailoo A; Jeffreys M; Hyde C
Health Technol Assess; 2012; 16(21):1-470. PubMed ID: 22541366
[TBL] [Abstract][Full Text] [Related]
16. Cholinesterase inhibitors and non-steroidal anti-inflammatory drugs as Alzheimer's disease therapies: an updated umbrella review of systematic reviews and meta-analyses.
Wang CH; Wang LS; Zhu N
Eur Rev Med Pharmacol Sci; 2016 Nov; 20(22):4801-4817. PubMed ID: 27906438
[TBL] [Abstract][Full Text] [Related]
17. Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia.
Parsons C; Lim WY; Loy C; McGuinness B; Passmore P; Ward SA; Hughes C
Cochrane Database Syst Rev; 2021 Feb; 2(2):CD009081. PubMed ID: 35608903
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological interventions for apathy in Alzheimer's disease.
Ruthirakuhan MT; Herrmann N; Abraham EH; Chan S; Lanctôt KL
Cochrane Database Syst Rev; 2018 May; 5(5):CD012197. PubMed ID: 29727467
[TBL] [Abstract][Full Text] [Related]
19. Association between chronic stress and Alzheimer's disease: Therapeutic effects of Saffron.
Saeedi M; Rashidy-Pour A
Biomed Pharmacother; 2021 Jan; 133():110995. PubMed ID: 33232931
[TBL] [Abstract][Full Text] [Related]
20. Donepezil for dementia due to Alzheimer's disease.
Birks JS; Harvey RJ
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD001190. PubMed ID: 29923184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
